AI assistant
Sending…
INSMED Inc — Director's Dealing 2013
Jan 15, 2013
30150_dirs_2013-01-15_8ba73657-d879-4524-b609-76eda7b56d5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED INC (INSM)
CIK: 0001104506
Period of Report: 2013-01-11
Reporting Person: SHAROKY MELVIN MD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-14 | Common Stock | M | 10174 | — | Acquired | 157947 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-14 | Restricted Stock Units | $ | M | 10174 | Disposed | Common Stock (10174) | Direct | |
| 2013-01-11 | Restricted Stock Units | $ | A | 8955 | Acquired | Common Stock (8955) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $ | Common Stock (5250) | 5250 | Direct |
Footnotes
F1: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
F2: The RSU's have a one year cliff vesting period, provided that the director attends at least 75% of the meetings of the Board. Vested shares are delivered within 30 days of vesting date.
F3: Amount represents grants outstanding from previous transactions.
More from INSMED Inc
Regulatory Filings
2026
May 15
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Report Publication Announcement
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19